NirmalBang

Market Performance

BIOCON LTD.

NSE : BIOCONBSE : 532523ISIN CODE : INE376G01013INE376G01013Industry : Pharmaceuticals & DrugsPharmaceuticals & DrugsHouse : Private
BSE227.80-4.6 (-1.98 %)
PREV CLOSE(Rs.)232.40
OPEN PRICE(Rs.)228.00
BID PRICE (QTY) 227.80 (125)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 333769
TODAY'S LOW / HIGH(Rs.)224.10 231.40
52 WK LOW / HIGH(Rs.)217.1 359.18
NSE228.00-4.45 (-1.91 %)
PREV CLOSE(Rs.)232.45
OPEN PRICE(Rs.)225.10
BID PRICE (QTY) 228.00 (2711)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4433182
TODAY'S LOW / HIGH(Rs.)224.00 231.45
52 WK LOW / HIGH(Rs.)217.05 359

Smart Quotes

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)
761.47
Dividend Yield(%)
0.22
TTM EPS (Rs.)
3.21
P/E Ratio
71.00
Book Value (Rs.)
62.31
Face Value (Rs.)
5
MCap (Rs. in Mn)
273360.00
Price/Earning (TTM)
52.13
Price/Sales (TTM)
10.15
Price/Book (MRQ)
3.66
PAT Margin (%)
17.08
ROCE (%)
7.89
Incorporation Year : 29-11 1978

Management Info :

Kiran Mazumdar-Shaw - Chairman Kiran Mazumdar-Shaw - Managing Director

Registered Office :

Address : 20th Km,Hosur Road,Electronic City,
Bengaluru,
Karnataka-560100

Phone : 080 2808 2808

Website : www.biocon.com

Registrars Details :

Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX

NEWS

08Aug Biocon informs about analyst meet
Biocon has informed that meetings were conducted with Institutional Inve..
01Aug Biocon, Mylan launch Ogivri in Australia
Biocon and Mylan have launched First Trastuzumab Biosimilar, Ogivri in A..
01Aug Announcement under Regulation 30 (LOD
Mylan and Biocon Launch First Trastuzumab Biosimilar, Ogivri?, in Australia

Financials

QTR Jun 19 ANNUAL 19
Net Profit11194927
Gross Profit 1562 5521
Operating Profit 987 5031
Net Sales 4808 28847
Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
 1708.40 (1.53%)
M.Cap (Rs. in Cr)4271.00
Everest Organics (BSE)
 172.65 (17.45%)
M.Cap (Rs. in Cr)138.12
Piramal Enterprises (BSE)
 1782.55 (0.90%)
M.Cap (Rs. in Cr)35445.39
Ajanta Pharma (BSE)
 996.45 (1.56%)
M.Cap (Rs. in Cr)8694.50

Shareholding Pattern

PROMOTERS
60.67%
NON-INSTITUTION
18.61%
MUTUAL FUNDS/UTI
3.01%
FI/BANKS/INSURANCE
1.26%
GOVERNMENT
0%
FII
0%

About Biocon Ltd.

Biocon Ltd. was incorporated in the year 29-11-1978. Its today's share price is 227.8. Its current market capitalisation stands at Rs 27336 Cr. In the latest quarter, company has reported Gross Sales of Rs. 55144 Cr and Total Income of Rs.56588 Cr. The company's management includes Mayank Verma, Vijay Kuchroo, Daniel M Bradbury, Jeremy Levin, John Shaw, Bobby Parikh, Russell Walls, M Damodaran, Ravi Mazumdar, Mary Harney, Kiran Mazumdar-Shaw, Kiran Mazumdar-Shaw, Arun Chandavarkar. It is listed on the BSE with a BSE Code of 532523 , NSE with an NSE Symbol of BIOCON and ISIN of INE376G01013. It's Registered office is at 20th Km,Hosur Road,Electronic CityBengaluru-560100, Karnataka. Their Registrars are ACC Ltd. It's auditors are BSR & Co LLP, SR Batliboi & Associates, SR Batliboi & Associates LLP

close X

Download Client Registration Documents